Sparsentan can be used as option to treat primary immunoglobulin A nephropathy (IgAN) in adults with a:
- urine protein excretion of 1.0 g/day or more, or
- urine protein-to-creatinine ratio (UPCR) of 0.75 g/g or more. (TA1074)
| Pack |
|---|
| 30 tablet |
| Pack |
|---|
| 30 tablet |





